ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Deca (nandrolone) added to trt and wow!!
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 164731" data-attributes="member: 13851"><p><span style="color: rgb(184, 49, 47)">[USER=15043]@Gman86[/USER]</span></p><p></p><p>Regarding the so called "stupid" <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="smilie smilie--sprite smilie--sprite11" alt=":rolleyes:" title="Roll Eyes :rolleyes:" loading="lazy" data-shortname=":rolleyes:" /> TruT calculator as you say.....tread lightly!</p><p></p><p>We are not dealing with amateurs here.</p><p></p><p></p><p></p><p><span style="font-size: 22px"><strong>About Function Promoting Therapies</strong></span></p><p></p><p>Function Promoting Therapies, LLC, and Tesvgen, the commercialization arm of FPT, LLC, were established in 2012. The company’s goals are to provide:</p><p></p><ul> <li data-xf-list-type="ul"><span style="color: rgb(184, 49, 47)">Advanced diagnostic algorithms that improve accuracy in the diagnosis of male reproductive disorders</span></li> <li data-xf-list-type="ul"><span style="color: rgb(184, 49, 47)">Enabling tools to enhance compliance and improve treatment outcomes for male reproductive disorders</span></li> <li data-xf-list-type="ul"><span style="color: rgb(184, 49, 47)">Advanced tools for dosimetry to optimize testosterone therapy</span></li> </ul><p></p><p><span style="color: rgb(184, 49, 47)"><strong>FPT has focused its initial efforts at developing the TruT product line </strong></span>and its Men’s Health franchise. <span style="color: rgb(0, 0, 0)">The Company strives to innovate at a high level, maintain our access to academic research and pre-eminence in this content area, and to optimally balance research and commercial success.</span></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>We are based in the heart of Boston within reach of some of the most renowned endocrine research and clinical centers in the world.</strong></span><span style="color: rgb(0, 0, 0)"> Our research partners are spread throughout USA and we have research ties with leading institutions in Europe. </span><span style="color: rgb(184, 49, 47)"><strong>These networks provide us the opportunity</strong></span> <span style="color: rgb(184, 49, 47)"><strong>to share and </strong></span><span style="color: rgb(44, 130, 201)"><strong>validate our findings </strong></span><span style="color: rgb(184, 49, 47)"><strong>and enable us to leverage from a global palette of resources. </strong></span></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>Our access to a network of academic experts at leading academic institutions </strong></span>also means that we are in tune with the upcoming changes in treatment patterns or recommendation of professional societies.</p><p></p><p></p><p></p><p><span style="font-size: 22px"><strong>Partners and Collaborations</strong></span></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">We continue to work with collaborators in academia and the wider industry for exciting new applications and further development of TruT™.</span></strong> Some of our existing partnerships include:</p><p></p><p></p><p><strong>Johns Hopkins University </strong>‐ <span style="color: rgb(184, 49, 47)">Diagnosis and management of hypogonadism in HIV and co-infections.</span></p><p></p><p><strong>The Mayo Clinic </strong>‐ <span style="color: rgb(184, 49, 47)">Personalized algorithm and therapy development.</span></p><p></p><p><strong>Karolinska Institute</strong> ‐ <span style="color: rgb(184, 49, 47)">Dynamics of free testosterone levels after surgical interventions in men and women.</span></p><p></p><p><a href="https://www.regionh.dk/" target="_blank"><strong><span style="color: rgb(0, 0, 0)">regionh.dk</span></strong></a> - <span style="color: rgb(184, 49, 47)">Examining population reference ranges of free testosterone for Danish cohorts.</span></p><p></p><p><strong>UCLA School of Nursing</strong> ‐ <span style="color: rgb(184, 49, 47)">Examining the dynamic role of multiple hormones in altering transport and bioavailability.</span></p><p></p><p><strong>Boston IVF </strong>‐ <span style="color: rgb(184, 49, 47)">Developing a novel platform for rational treatment and management of in-vitro fertilization interventions.</span></p><p></p><p><strong>Myosyntax </strong>‐ <span style="color: rgb(184, 49, 47)">Dynamics of testosterone bioavailability during caloric restriction.</span></p><p></p><p></p><p></p><p></p><p><span style="font-size: 18px"><strong>Ravi Jasuja, Ph.D.</strong></span></p><p><span style="color: rgb(184, 49, 47)">Chief Scientific Officer</span></p><p></p><p><span style="color: rgb(0, 0, 0)"><strong>Dr. Jasuja serves as the Chief Scientific Officer</strong></span> <strong>of the Function Promoting Therapies, LLC <span style="color: rgb(184, 49, 47)">and</span></strong><span style="color: rgb(184, 49, 47)"><strong> is</strong> <strong>an expert in</strong></span> <span style="color: rgb(184, 49, 47)"><strong>the use of biophysical techniques for investigating the interactions of steroid hormones with their cognate receptors and binding proteins.</strong></span><strong> <span style="color: rgb(44, 130, 201)">He led innovative research that uncovered the mechanistic origin of errors in the current model of testosterone binding to SHBG and provided the insight that led to the generation of the new TruT™ method for determining free testosterone concentration.</span></strong></p><p></p><p></p><p></p><p>As I stated before there are three heavy weights in the field behind the invention of <strong><span style="color: rgb(184, 49, 47)">TruT.</span></strong></p><p></p><p><span style="color: rgb(184, 49, 47)">Ravi Jasuja, Shalender Bhasin and Mikhail N Zakharov. </span></p><p></p><p>If you seriously believe that factors which could affect SHBG:T binding were not taken into account during the development of the newer calculated TruT algorithm.....than you truly are senseless.</p><p></p><p>A significant amount of research, money and time have been invested since 2012.</p></blockquote><p></p>
[QUOTE="madman, post: 164731, member: 13851"] [COLOR=rgb(184, 49, 47)][USER=15043]@Gman86[/USER][/COLOR] Regarding the so called "stupid" :rolleyes: TruT calculator as you say.....tread lightly! We are not dealing with amateurs here. [SIZE=22px][B]About Function Promoting Therapies[/B][/SIZE] Function Promoting Therapies, LLC, and Tesvgen, the commercialization arm of FPT, LLC, were established in 2012. The company’s goals are to provide: [LIST] [*][COLOR=rgb(184, 49, 47)]Advanced diagnostic algorithms that improve accuracy in the diagnosis of male reproductive disorders[/COLOR] [*][COLOR=rgb(184, 49, 47)]Enabling tools to enhance compliance and improve treatment outcomes for male reproductive disorders[/COLOR] [*][COLOR=rgb(184, 49, 47)]Advanced tools for dosimetry to optimize testosterone therapy[/COLOR] [/LIST] [COLOR=rgb(184, 49, 47)][B]FPT has focused its initial efforts at developing the TruT product line [/B][/COLOR]and its Men’s Health franchise. [COLOR=rgb(0, 0, 0)]The Company strives to innovate at a high level, maintain our access to academic research and pre-eminence in this content area, and to optimally balance research and commercial success.[/COLOR] [COLOR=rgb(184, 49, 47)][B]We are based in the heart of Boston within reach of some of the most renowned endocrine research and clinical centers in the world.[/B][/COLOR][COLOR=rgb(0, 0, 0)] Our research partners are spread throughout USA and we have research ties with leading institutions in Europe. [/COLOR][COLOR=rgb(184, 49, 47)][B]These networks provide us the opportunity[/B][/COLOR] [COLOR=rgb(184, 49, 47)][B]to share and [/B][/COLOR][COLOR=rgb(44, 130, 201)][B]validate our findings [/B][/COLOR][COLOR=rgb(184, 49, 47)][B]and enable us to leverage from a global palette of resources. [/B][/COLOR] [COLOR=rgb(184, 49, 47)][B]Our access to a network of academic experts at leading academic institutions [/B][/COLOR]also means that we are in tune with the upcoming changes in treatment patterns or recommendation of professional societies. [SIZE=22px][B]Partners and Collaborations[/B][/SIZE] [B][COLOR=rgb(184, 49, 47)]We continue to work with collaborators in academia and the wider industry for exciting new applications and further development of TruT™.[/COLOR][/B] Some of our existing partnerships include: [B]Johns Hopkins University [/B]‐ [COLOR=rgb(184, 49, 47)]Diagnosis and management of hypogonadism in HIV and co-infections.[/COLOR] [B]The Mayo Clinic [/B]‐ [COLOR=rgb(184, 49, 47)]Personalized algorithm and therapy development.[/COLOR] [B]Karolinska Institute[/B] ‐ [COLOR=rgb(184, 49, 47)]Dynamics of free testosterone levels after surgical interventions in men and women.[/COLOR] [URL='https://www.regionh.dk/'][B][COLOR=rgb(0, 0, 0)]regionh.dk[/COLOR][/B][/URL] - [COLOR=rgb(184, 49, 47)]Examining population reference ranges of free testosterone for Danish cohorts.[/COLOR] [B]UCLA School of Nursing[/B] ‐ [COLOR=rgb(184, 49, 47)]Examining the dynamic role of multiple hormones in altering transport and bioavailability.[/COLOR] [B]Boston IVF [/B]‐ [COLOR=rgb(184, 49, 47)]Developing a novel platform for rational treatment and management of in-vitro fertilization interventions.[/COLOR] [B]Myosyntax [/B]‐ [COLOR=rgb(184, 49, 47)]Dynamics of testosterone bioavailability during caloric restriction.[/COLOR] [SIZE=18px][B]Ravi Jasuja, Ph.D.[/B][/SIZE] [COLOR=rgb(184, 49, 47)]Chief Scientific Officer[/COLOR] [COLOR=rgb(0, 0, 0)][B]Dr. Jasuja serves as the Chief Scientific Officer[/B][/COLOR] [B]of the Function Promoting Therapies, LLC [COLOR=rgb(184, 49, 47)]and[/COLOR][/B][COLOR=rgb(184, 49, 47)][B] is[/B] [B]an expert in[/B][/COLOR] [COLOR=rgb(184, 49, 47)][B]the use of biophysical techniques for investigating the interactions of steroid hormones with their cognate receptors and binding proteins.[/B][/COLOR][B] [COLOR=rgb(44, 130, 201)]He led innovative research that uncovered the mechanistic origin of errors in the current model of testosterone binding to SHBG and provided the insight that led to the generation of the new TruT™ method for determining free testosterone concentration.[/COLOR][/B] As I stated before there are three heavy weights in the field behind the invention of [B][COLOR=rgb(184, 49, 47)]TruT.[/COLOR][/B] [COLOR=rgb(184, 49, 47)]Ravi Jasuja, Shalender Bhasin and Mikhail N Zakharov. [/COLOR] If you seriously believe that factors which could affect SHBG:T binding were not taken into account during the development of the newer calculated TruT algorithm.....than you truly are senseless. A significant amount of research, money and time have been invested since 2012. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Deca (nandrolone) added to trt and wow!!
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top